Literature DB >> 30715093

Utility of a Simple and Robust Flow Cytometry Assay for Rapid Clonality Testing in Mature Peripheral T-Cell Lymphomas.

Natasha D Novikov1,2, Gabriel K Griffin1,2, Graham Dudley1, Mai Drew1, Vanesa Rojas-Rudilla1, Neal I Lindeman1,2, David M Dorfman1,2.   

Abstract

OBJECTIVES: Flow cytometry immunophenotyping is limited by poor resolution of T-cell clones. A newly described antibody was recently used to distinguish normal peripheral blood T cells from malignant T-cell clones. Here, we evaluate this antibody as a new diagnostic tool for detecting T-cell clonality in mature peripheral T-cell lymphomas.
METHODS: Immunostaining for the T-cell receptor β chain constant region 1 (TRBC1) along with routine T-cell markers was performed on 51 peripheral blood and two bone marrow samples submitted to the flow cytometry laboratory for suspected T-cell malignancy.
RESULTS: TRBC immunophenotyping identified malignant T-cell clones with 97% sensitivity and 91% specificity. Findings correlated with molecular T-cell clonality testing. In cases with equivocal molecular results, TRBC1 immunophenotyping provided additional diagnostic information.
CONCLUSIONS: TRBC1 flow cytometric immunophenotyping is a robust and inexpensive method for identifying T-cell clonality that could easily be incorporated into routine flow cytometric practice. © American Society for Clinical Pathology, 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Sézary syndrome; T-LGL leukemia; T-cell receptor β chain; TRBC1

Mesh:

Substances:

Year:  2019        PMID: 30715093     DOI: 10.1093/ajcp/aqy173

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics.

Authors:  Min Shi; Horatiu Olteanu; Dragan Jevremovic; Rong He; David Viswanatha; Heidi Corley; Pedro Horna
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

2.  Analysis of the Expression of the TRBC1 in T lymphocyte tumors.

Authors:  Man Chen; Aixian Wang; Shuqiang Liu; Xueying Wu; Meiwei Gong; Junyi Zhen; Minjing Fu; Hui Wang
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-24       Impact factor: 0.900

Review 3.  Emerging Role of T-cell Receptor Constant β Chain-1 (TRBC1) Expression in the Flow Cytometric Diagnosis of T-cell Malignancies.

Authors:  Pedro Horna; Min Shi; Horatiu Olteanu; Ulrika Johansson
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

Review 4.  Persistent Large Granular Lymphocyte Clonal Expansions: "The Root of Many Evils"-And of Some Goodness.

Authors:  Carlos Bravo-Pérez; Salvador Carrillo-Tornel; Esmeralda García-Torralba; Andrés Jerez
Journal:  Cancers (Basel)       Date:  2022-03-05       Impact factor: 6.639

5.  Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India.

Authors:  Prashant R Tembhare; Gaurav Chatterjee; Anumeha Chaturvedi; Niharika Dasgupta; Twinkle Khanka; Shefali Verma; Sitaram G Ghogale; Nilesh Deshpande; Karishma Girase; Manju Sengar; Bhausaheb Bagal; Hasmukh Jain; Dhanalaxmi Shetty; Sweta Rajpal; Nikhil Patkar; Tushar Agrawal; Sridhar Epari; Tanuja Shet; Papagudi G Subramanian; Sumeet Gujral
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

Review 6.  Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping.

Authors:  Melissa P Pulitzer; Pedro Horna; Julia Almeida
Journal:  Cytometry B Clin Cytom       Date:  2020-06-09       Impact factor: 3.248

7.  High-Sensitive TRBC1-Based Flow Cytometric Assessment of T-Cell Clonality in Tαβ-Large Granular Lymphocytic Leukemia.

Authors:  Noemí Muñoz-García; F Javier Morán-Plata; Neus Villamor; Margarida Lima; Susana Barrena; Sheila Mateos; Carolina Caldas; Jacques J M van Dongen; Alberto Orfao; Julia Almeida
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.